{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:09:04Z","timestamp":1781719744404,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2022-0150"],"award-info":[{"award-number":["6-2022-0150"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:sup>18<\/jats:sup>Fluorine-Fluoro-deoxy-glucose (<jats:sup>18<\/jats:sup>F-FDG) positron emission tomography (PET) is widely used for diagnosing various malignant tumors and evaluating metabolic activities. Although the usefulness of <jats:sup>18<\/jats:sup>F-FDG PET has been reported in several endocrine diseases, studies on pituitary disease are extremely limited. To evaluate whether dexamethasone (DEX) suppression can improve <jats:sup>18<\/jats:sup>F-FDG PET for the localization of adrenocorticotropic hormone-secreting adenomas in the pituitary gland in Cushing\u2019s disease (CD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 22 patients with CD who underwent PET imaging before and after DEX administration. We compared the success rates of PET before and after DEX suppression, magnetic resonance imaging (MRI), and bilateral inferior petrosal sinus sampling (BIPSS). We determined the final locations of adenomas based on intraoperative multiple-staged resection and tumor tissue identification using frozen sections. Standardized uptake value (SUV) were analyzed to confirm the change of intensity of adenomas on PET.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-two patients were included (age at diagnosis: 37 [13\u201356] years), and most were women (90.91%). Pituitary adenomas compared to normal pituitaries showed increased maximum SUV after DEX suppression but without statistical significance (1.13 versus. 1.21, z=-0.765, <jats:italic>P<\/jats:italic>\u2009=\u20090.444). After DEX suppression, the mean and maximum SUV of adenomas showed a positive correlation with nadir cortisol levels in high-dose DEX suppression test (Rho\u2009=\u20090.554, <jats:italic>P<\/jats:italic>\u2009=\u20090.007 and Rho\u2009=\u20090.503, <jats:italic>P<\/jats:italic>\u2009=\u20090.017, respectively). In reference sites, mean SUV of cerebellum was significantly decreased (7.65 vs. 6.40, <jats:italic>P<\/jats:italic>\u2009=\u20090.006<jats:sup>*<\/jats:sup>), but those of the thalamus and gray matter was increased after DEX suppression (thalamus, 8.70 vs. 11.20, <jats:italic>P<\/jats:italic>\u2009=\u20090.010<jats:sup>*<\/jats:sup>; gray matter, 6.25 vs. 7.95, <jats:italic>P<\/jats:italic>\u2009=\u20090.010<jats:sup>*<\/jats:sup>).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>DEX suppression did not improve <jats:sup>18<\/jats:sup>F-FDG PET\/CT localization in patients with CD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-023-00600-8","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T10:02:46Z","timestamp":1694512966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dexamethasone suppression for 18F-FDG PET\/CT to localize ACTH-secreting pituitary tumors"],"prefix":"10.1186","volume":"23","author":[{"given":"Kyungwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-9630","authenticated-orcid":false,"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"600_CR1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing\u2019s syndrome. The Lancet. 2006;367:1605\u201317.","journal-title":"The Lancet"},{"key":"600_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","volume":"92","author":"C Steffensen","year":"2010","unstructured":"Steffensen C, Bak AM, Rubeck KZ, J\u00f8rgensen JOL. Epidemiology of Cushing\u2019s syndrome. Neuroendocrinology. 2010;92:1\u20135.","journal-title":"Neuroendocrinology"},{"key":"600_CR3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing\u2019s syndrome. The Lancet. 2015;386:913\u201327.","journal-title":"The Lancet"},{"key":"600_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/jc.2002-021753","volume":"88","author":"T Moshang Jr","year":"2003","unstructured":"Moshang T Jr. Cushing\u2019s Disease, 70 years later \u2026 and the beat goes on. J Clin Endocrinol Metab. 2003;88:31\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR5","first-page":"3114","volume":"80","author":"D Bochicchio","year":"1995","unstructured":"Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing\u2019s disease treated by transsphenoidal surgery: a retrospective study by the european Cushing\u2019s Disease Survey Group. J Clin Endocrinol Metab. 1995;80:3114\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3171\/JNS\/2008\/109\/10\/0751","volume":"109","author":"DM Prevedello","year":"2008","unstructured":"Prevedello DM, Pouratian N, Sherman J, Jane JA, Vance ML, Lopes MB, et al. Management of Cushing\u2019s disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging: clinical article. J Neurosurg. 2008;109:751\u20139.","journal-title":"J Neurosurg"},{"key":"600_CR7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","volume":"56","author":"DA Rees","year":"2002","unstructured":"Rees DA, Hanna FWF, Davies JS, Mills RG, Vafidis J, Scanlon MF. Long-term follow-up results of transsphenoidal surgery for Cushing\u2019s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf). 2002;56:541\u201351.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"600_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00006123-200003000-00005","volume":"46","author":"PL Semple","year":"2000","unstructured":"Semple PL, Vance ML, Findling J, Laws ER. Transsphenoidal surgery for Cushing\u2019s disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery. 2000;46:553\u20138. discussion 558\u2013559.","journal-title":"Neurosurgery"},{"key":"600_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3171\/2014.10.JNS14911","volume":"122","author":"P Chittiboina","year":"2015","unstructured":"Chittiboina P, Montgomery BK, Millo C, Herscovitch P, Lonser RR. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease. J Neurosurg. 2015;122:791\u20137.","journal-title":"J Neurosurg"},{"key":"600_CR10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2265.2009.03646.x","volume":"72","author":"IN Chowdhury","year":"2010","unstructured":"Chowdhury IN, Sinaii N, Oldfield EH, Patronas N, Nieman LK. A change in pituitary magnetic resonance imaging protocol detects ACTH-secreting tumours in patients with previously negative results. Clin Endocrinol (Oxf). 2010;72:502\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"600_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1148\/radiology.189.1.8372195","volume":"189","author":"DA Finelli","year":"1993","unstructured":"Finelli DA, Kaufman B. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging. Radiology. 1993;189:205\u201310.","journal-title":"Radiology"},{"key":"600_CR12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cen.12069","volume":"78","author":"R Kasaliwal","year":"2013","unstructured":"Kasaliwal R, Sankhe SS, Lila AR, Budyal SR, Jagtap VS, Sarathi V, et al. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas. Clin Endocrinol (Oxf). 2013;78:825\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"600_CR13","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.3390\/ijms21239132","volume":"21","author":"H Fukuoka","year":"2020","unstructured":"Fukuoka H, Shichi H, Yamamoto M, Takahashi Y. The Mechanisms Underlying Autonomous adrenocorticotropic hormone secretion in Cushing\u2019s Disease. Int J Mol Sci. 2020;21:9132.","journal-title":"Int J Mol Sci"},{"key":"600_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(02)00280-0","volume":"197","author":"SWJ Lamberts","year":"2002","unstructured":"Lamberts SWJ. Glucocorticoid receptors and Cushing\u2019s disease. Mol Cell Endocrinol. 2002;197:69\u201372.","journal-title":"Mol Cell Endocrinol"},{"key":"600_CR15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.beem.2006.09.005","volume":"20","author":"EFC van Rossum","year":"2006","unstructured":"van Rossum EFC, Lamberts SWJ. Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach. Best Pract Res Clin Endocrinol Metab. 2006;20:611\u201326.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"600_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11102-009-0180-4","volume":"12","author":"AS Alzahrani","year":"2009","unstructured":"Alzahrani AS, Farhat R, Al-Arifi A, Al-Kahtani N, Kanaan I, Abouzied M. The diagnostic value of fused positron emission tomography\/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing\u2019s disease. Pituitary. 2009;12:309\u201314.","journal-title":"Pituitary"},{"key":"600_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.177.1.2399336","volume":"177","author":"B De Souza","year":"1990","unstructured":"De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P, et al. Pituitary microadenomas: a PET study. Radiology. 1990;177:39\u201344.","journal-title":"Radiology"},{"key":"600_CR18","first-page":"296","volume":"28","author":"RJ Campeau","year":"2003","unstructured":"Campeau RJ, David O, Dowling AM. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med. 2003;28:296\u20138.","journal-title":"Clin Nucl Med"},{"key":"600_CR19","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00259-010-1571-5","volume":"37","author":"SY Jeong","year":"2010","unstructured":"Jeong SY, Lee S-W, Lee HJ, Kang S, Seo J-H, Chun KA, et al. Incidental pituitary uptake on whole-body 18F-FDG PET\/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2010;37:2334\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"600_CR20","doi-asserted-by":"crossref","first-page":"55544","DOI":"10.18632\/oncotarget.15417","volume":"8","author":"H Ju","year":"2017","unstructured":"Ju H, Zhou J, Pan Y, Lv J, Zhang Y. Evaluation of pituitary uptake incidentally identified on 18F-FDG PET\/CT scan. Oncotarget. 2017;8:55544\u20139.","journal-title":"Oncotarget"},{"key":"600_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.rlu.0000191779.75532.05","volume":"31","author":"CW Koo","year":"2006","unstructured":"Koo CW, Bhargava P, Rajagopalan V, Ghesani M, Sims-Childs H, Kagetsu NJ. Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging. Clin Nucl Med. 2006;31:42\u20133.","journal-title":"Clin Nucl Med"},{"key":"600_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","volume":"65","author":"J Boyle","year":"2019","unstructured":"Boyle J, Patronas NJ, Smirniotopoulos J, Herscovitch P, Dieckman W, Millo C, et al. CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease. Endocrine. 2019;65:155\u201365.","journal-title":"Endocrine"},{"key":"600_CR23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jc.2009-1672","volume":"95","author":"E Valassi","year":"2010","unstructured":"Valassi E, Biller BMK, Swearingen B, Pecori Giraldi F, Losa M, Mortini P, et al. Delayed remission after transsphenoidal surgery in patients with Cushing\u2019s disease. J Clin Endocrinol Metab. 2010;95:601\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12020-021-02848-1","volume":"75","author":"C Dai","year":"2022","unstructured":"Dai C, Feng M, Sun B, Bao X, Yao Y, Deng K, et al. Surgical outcome of transsphenoidal surgery in Cushing\u2019s disease: a case series of 1106 patients from a single center over 30 years. Endocrine. 2022;75:219\u201327.","journal-title":"Endocrine"},{"key":"600_CR25","doi-asserted-by":"crossref","first-page":"101485","DOI":"10.1016\/j.beem.2021.101485","volume":"35","author":"JM Hinojosa-Amaya","year":"2021","unstructured":"Hinojosa-Amaya JM, Cuevas-Ramos D. The definition of remission and recurrence of Cushing\u2019s disease. Best Pract Res Clin Endocrinol Metab. 2021;35:101485.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"600_CR26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9:847\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"600_CR27","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing\u2019s syndrome: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5469\/neuroint.2011.6.1.23","volume":"6","author":"JW Park","year":"2011","unstructured":"Park JW, Park S, Kim JL, Lee HY, Shin JE, Hyun DH, et al. Bilateral inferior petrosal sinus sampling by unilateral femoral venous approach. Neurointervention. 2011;6:23\u20136.","journal-title":"Neurointervention"},{"key":"600_CR29","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2011-2149","volume":"96","author":"ST Sharma","year":"2011","unstructured":"Sharma ST, Raff H, Nieman LK. Prolactin as a marker of successful catheterization during IPSS in patients with ACTH-Dependent Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2011;96:3687\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12020-011-9499-5","volume":"40","author":"JS Lim","year":"2011","unstructured":"Lim JS, Lee SK, Kim SH, Lee EJ, Kim SH. Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing\u2019s disease. Endocrine. 2011;40:452\u201361.","journal-title":"Endocrine"},{"key":"600_CR31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1471-6712.2005.00368.x","volume":"19","author":"U Jakobsson","year":"2005","unstructured":"Jakobsson U, Westergren A. Statistical methods for assessing agreement for ordinal data. Scand J Caring Sci. 2005;19:427\u201331.","journal-title":"Scand J Caring Sci"},{"key":"600_CR32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.78.2.8106630","volume":"78","author":"HL Dichek","year":"1994","unstructured":"Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing\u2019s syndrome. J Clin Endocrinol Metab. 1994;78:418\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR33","first-page":"152","volume":"18","author":"S Aytug","year":"2012","unstructured":"Aytug S, Laws ER, Vance ML. Assessment of the utility of the high-dose dexamethasone suppression test in confirming the diagnosis of cushing disease. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2012;18:152\u20137.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"600_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1742-1241.1996.tb10010.x","volume":"50","author":"S Sriussadaporn","year":"1996","unstructured":"Sriussadaporn S, Ploybutr S, Peerapatdit T, Plengvidhya N, Nitiyanant W, Vannasaeng S, et al. Nocturnal 8\u00a0mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing\u2019s syndrome. Br J Clin Pract. 1996;50:9\u201313.","journal-title":"Br J Clin Pract"},{"key":"600_CR35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nicl.2017.10.038","volume":"17","author":"S Liu","year":"2018","unstructured":"Liu S, Wang Y, Xu K, Ping F, Li F, Wang R, et al. Voxel-based comparison of brain glucose metabolism between patients with Cushing\u2019s disease and healthy subjects. NeuroImage Clin. 2018;17:354\u20138.","journal-title":"NeuroImage Clin"},{"key":"600_CR36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nicl.2016.08.018","volume":"12","author":"S Liu","year":"2016","unstructured":"Liu S, Wang Y, Xu K, Ping F, Wang R, Li F, et al. Brain glucose metabolism is associated with hormone level in Cushing\u2019s disease: a voxel-based study using FDG-PET. NeuroImage Clin. 2016;12:415\u20139.","journal-title":"NeuroImage Clin"},{"key":"600_CR37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C, Rosiers MHD, Patlak CS, Pettigrew KD, et al. The [14c]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, Procedure, and normal values in the conscious and anesthetized albino Rat1. J Neurochem. 1977;28:897\u2013916.","journal-title":"J Neurochem"},{"key":"600_CR38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semnuclmed.2008.02.005","volume":"38","author":"W Chen","year":"2008","unstructured":"Chen W, Silverman DHS. Advances in evaluation of primary brain tumors. Semin Nucl Med. 2008;38:240\u201350.","journal-title":"Semin Nucl Med"},{"key":"600_CR39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","volume":"195","author":"D Delbeke","year":"1995","unstructured":"Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology. 1995;195:47\u201352.","journal-title":"Radiology"},{"key":"600_CR40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.clinimag.2015.07.020","volume":"39","author":"K Meric","year":"2015","unstructured":"Meric K, Killeen RP, Abi-Ghanem AS, Soliman F, Novruzov F, Cakan E, et al. The use of 18F-FDG PET ratios in the differential diagnosis of common malignant brain tumors. Clin Imaging. 2015;39:970\u20134.","journal-title":"Clin Imaging"},{"key":"600_CR41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","volume":"48","author":"M Soret","year":"2007","unstructured":"Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932\u201345.","journal-title":"J Nucl Med"},{"key":"600_CR42","first-page":"107","volume":"33","author":"C Xin","year":"2011","unstructured":"Xin C, Rui-xue C, Hui P, Tao Y, Hui-Juan Z, Fang L. Value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in diagnosis and localization of Cushing\u2019s disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011;33:107\u201310.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-023-00600-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-023-00600-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-023-00600-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:53:23Z","timestamp":1700531603000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-023-00600-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1186\/s40644-023-00600-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data were collected under the conditions of regular clinical care with approval from the ethics committee of our hospital, and the requirement for written informed consent was waived owing to its retrospective design (institutional review board number: 2023-0110-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest that could be perceived as prejudicing the impartiality of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}